Publishing research using ab72069? Please let us know so that we can cite the reference in this datasheet.
ab72069 has been referenced in 2 publications.
Dine JL et al.The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.Breast Cancer Res Treat 155:235-51 (2016).
Leconet W et al.Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.Oncogene N/A:N/A (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"